Aspirin Foundation
Search
What is Aspirin?Uses of AspirinSuitabilityNews & EventsAbout the FoundationContact Us
  Home > News and Events > Media Releases > Another landmark for the world's wonder drug
News and Events man reading a news paper



News Briefs

Media Releases

Conferences
Photo Library


 

 

MEDIA RELEASE


22nd February 2007

Take aspirin regularly to reduce your chances of getting asthma

If, as an adult, you take a daily aspirin, you may well prevent yourself from developing asthma. That’s the message from a new analysis of the well-known American Physician’s Health Study . The Study, which followed more than 22,000 American male doctors, who were apparently healthy at the start of the study, is already famous for its reports on the benefits of a daily aspirin in preventing heart disease. After just under five years, for example, one ‘arm’ of the study – a comparison of a daily aspirin with placebo (a dummy tablet) – was stopped because the doctors taking the aspirin had 44 percent fewer heart attacks than those taking the placebo. It was largely from this study that we now give aspirin routinely to people at risk of heart attacks.

However, its protection against asthma may be more surprising. That’s because we know that for a small proportion of people (between 4 and 11 percent) with asthma, aspirin makes the asthma worse and can even induce an acute asthma attack. For that reason aspirin is rarely advised for people who already have the illness.

So why should we expect aspirin to prevent the start of asthma in adults? Several studies have previously suggested that people who take daily aspirin might be less likely to develop new asthma than expected . In asthma there is inflammation in the lungs, and aspirin is known to be a powerful anti-inflammatory agent, so that there is a theoretical rationale for its use. However, there was a need for this suggestion to be confirmed in a larger, well-controlled study.

The Physician’s Health Study has provided that confirmation. The doctors, none of whom had ever had asthma before entering the study, were asked to take aspirin every day for 18 weeks before starting on the study. None reacted badly (either with asthma or in any other way) to aspirin in this ‘run in’ period. They were then put in one of two groups of equal numbers. Half took daily aspirin and half took placebo. Over the next 4.9 years, 145 taking placebo and 113 taking aspirin developed asthma. This meant that 22 percent fewer men on aspirin than on placebo started to have the illness – a difference that was calculated statistically to be highly significant. When the authors compared men who took more than 15 aspirin tablets a month over the length of the study with those who never took aspirin the protection rose to 40 percent.

The authors concluded that aspirin may reduce the risk of the development of asthma in adults. This doesn’t imply, however, that aspirin can improve symptoms in people who already have asthma. Indeed it may make a small proportion of people with asthma worse.

They make a further point. Numbers of cases of asthma have risen steeply in the last thirty years in the United States, Britain and Australia. The authors postulate that there may be a link between this rise and the fact that we no longer give aspirin to children in these countries. Paracetamol is used instead. There are biochemical reasons to suppose that aspirin may specifically prevent asthma-inducing changes in the lungs of some children, and without the drug, many more children may have developed it than would otherwise have done so .


Ends

1.Barr RG Kurth T Stampfer MJ et al. Aspirin and Decreased Adult-Onset Asthma Am J Respir Crit Care Med 2007; 175:120-5

2. Barr RG Wentowski CC et al.  Prospective study of acetaminophen use and risk of newly diagnosed asthma among women.  Am J Respir Crit Care Med 2004; 169: 836-41

3. Varner AE Busse WW Lemanske RFJ. Hopothesis: decreasing use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma.  Ann Alergy Asthma Immunol 1998; 81: 347-51.